Skip to main navigation Skip to search Skip to main content

Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study

  • Chantal F. Stockem
  • , Alberto Gil-Jimenez
  • , Hamza Ali
  • , Jeroen van Dorp
  • , Nick van Dijk
  • , Maurits L. van Montfoort
  • , Maartje Alkemade
  • , Annegien Broeks
  • , Iris M. Seignette
  • , Erik Hooijberg
  • , Wim Brugman
  • , Rhianne Voogd
  • , Bas W. G. van Rhijn
  • , Laura S. Mertens
  • , Jeantine M. de Feijter
  • , Niven Mehra
  • , Antoine G. van der Heijden
  • , Richard P. Meijer
  • , Britt B. M. Suelmann
  • , Wouter Scheper
  • Lodewyk F. A. Wessels, Daniel J. Vis, Michiel S. van der Heijden
  • Netherlands Cancer Institute
  • University of Regensburg
  • Radboud University Nijmegen
  • Utrecht University
  • Delft University of Technology

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science